American college of gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.
Am J Gastroenterol. 109: S2-262.The Papyrus Ebers: the greatest Egyptian medical document.
Levin & Munksgaard, Copenhagen: 30-323.The Lancet Gastroenterology & HepatologyThe cost of constipation.
Lancet Gastroenterol Hepatol. 4: 8114.Lacy BE Mearin F Chang L et al.Bowel disorders.
Gastroenterology. 150: 1393-14075.Longstreth GF Thompson WG Chey WD Houghton LA Mearin F Spiller RCFunctional Bowel Disorders.
Gastroenterology. 130: 1480-14916.Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.
Am J Gastroenterol. 106: 1582-15917.Werth BL Williams KA Fisher MJ Pont LGDefining constipation to estimate its prevalence in the community: results from a national survey.
BMC Gastroenterol. 19: 1-78.What is new in Rome IV.
Korean Soc Neurogastroenterol Motil J Neurogastroenterol Motil. 23·2: 151-1639.Sperber AD Bangdiwala SI Drossman DA et al.Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study.
Gastroenterology. 160.1: 99-11410.Palsson OS Whitehead W Törnblom H Sperber AD Simren MPrevalence of Rome IV functional bowel disorders among adults in the united states, canada, and the United Kingdom.
Gastroenterology. 158: 1262-127311.Drossman DA Thompson WG TNIdentification of sub-groups of functional gastrointestinal disorders.
Gastroenterol Intl. 3: 159-17212.Thompson WG Longstreth GF Drossman DA Heaton KW Irvine EJ Müller-Lissner SAFunctional bowel disorders and functional abdominal pain.
Gut. 45: II43-II4713.Higgins J Thompson S Deeks J Douglas GMeasuring inconsistency in meta-analyses.
Br Med J. 327: 557-56014.Egger M Davey-Smith G Schneider M Minder CBias in meta-analysis detected by a simple, graphical test.
Br Med J. 315: 629-63415.Sterne JAC Sutton AJ Ioannidis JPA et al.Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
BMJ. 343: 1-816.Drossman DA Li Z Andruzzi E et al.US householder survey of functional gastrointestinal disorders—prevalence, sociodemography, and health impact.
Dig Dis Sci. 38: 1569-158017.Talley NJ Weaver AL Zinsmeister AR et al.Functional constipation and outlet delay: a population-based study.
Gastroenterology. 105: 781-79018.Choo KY Choi MG Choi H et al.The prevalences of gastrointestinal symptoms in a rural community in Korea.
Kor J Neurogastroenterol Motil. 6: 31-4319.Koloski NA Talley NJ Boyce PMThe impact of functional gastrointestinal disorders on quality of life.
Am J Gastroenterol. 95: 67-7120.Boyce PM Talley NJ Burke C Koloski NAEpidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study.
Intern Med J. 36: 28-3621.Bytzer P Talley NJ Leemon M et al.Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults.
Arch Intern Med. 161: 1989-199622.An epidemiologic study of bowel habit in adult non-patient population in Beijing area.
Natl Med J China. 81: 1287-129023.Pare P Ferrazzi S Thompson WG Irvine EJ Rance LAn epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking.
Am J Gastroenterol. 96: 3130-313724.Cheng C Chan AOO Hui WM Lam SKCoping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study.
Aliment Pharmacol Ther. 18: 319-32625.Garrigues V Gálvez C Ortiz V Ponce M Nos P Ponce JPrevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain.
Am J Epidemiol. 159: 520-52626.Howell S Quine S Talley NLow social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults.
Scand J Gastroenterol. 41: 657-66627.Jun DW Park HY Lee OY et al.A population-based study on bowel habits in a Korean community: Prevalence of functional constipation and self-reported constipation.
Dig Dis Sci. 51: 1471-147728.Chronic constipation: a survey of the patient perspective.
Aliment Pharmacol Ther. 25: 599-60829.Basaranoglu M Celebi S Ataseven H Rahman S Deveci SE Acik YPrevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community.
Digestion. 77: 10-1530.Hillilä MT Hämäläinen J Heikkinen ME Färkkilä MAGastrointestinal complaints among subjects with depressive symptoms in the general population.
Aliment Pharmacol Ther. 28: 648-65431.Jeong JJ Choi MG Cho YS et al.Chronic gastrointestinal symptoms and quality of life in the Korean population.
World J Gastroenterol. 14: 6388-639432.Collete VL Araújo CL Madruga SWPrevalence of intestinal constipation and associated factors: a population-based study in Pelotas, Rio Grande do Sul State, Brazil, 2007.
Cad Saude Publica. 26: 1391-140233.Papatheodoridis GV Vlachogiannakos J Karaitianos I Karamanolis DGA Greek survey of community prevalence and characteristics of constipation.
Eur J Gastroenterol Hepatol. 22: 354-36034.Sorouri M Pourhoseingholi MA Vahedi M et al.Functional bowel disorders in Iranian population using Rome III criteria.
Saudi J Gastroenterol. 16: 154-16035.Fosnes GS Lydersen S Farup PGConstipation and diarrhoea—common adverse drug reactions? A cross sectional study in the general population.
BMC Clin Pharmacol. 11: 1-936.Hoch R Chey W Olden K Spiegel B Quigley EM Schoenfeld PSymptom frequency, health care seeking behavior, and satisfaction with therapy among chronic constipation (CC) patients with both constipation and abdominal symptoms: results of a population-based survey.
Neurogastroenterol Motil. 23: 29-3037.Lazebnik L Prilepskaia S Baryshnikov E Parfenov A Kosacheva TPrevalence and risk factors of constipation in the adult population of Moscow (according to population-based study MUSA).
Eksp Klin Gastroenterol. 3: 68-7338.Zhao YF Ma XQ Wang R et al.Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC).
Aliment Pharmacol Ther. 34: 1020-102939.Chang FY Chen PH Wu TC et al.Prevalence of functional gastrointestinal disorders in Taiwan: Questionnaire-based survey for adults based on the Rome III criteria.
Asia Pac J Clin Nutr. 21: 594-60040.Leelakusolvong S Charatcharoenwitthaya P Maneerattanaporn M et al.Prevalence of lower functional gastrointestinal disorders and the associated factors among Thai healthy subjects.
J Gastroenterol Hepatol. 27: 14941.López-Colombo A Morgan D Bravo-González D Montiel-Jarquín A Méndez-Martínez S Schmulson MThe epidemiology of functional gastrointestinal disorders in Mexico: a population-based study.
Gastroenterol Res Pract. 201260617442.Survey of bowel habits and its relation to physical activity and fiber intake in brunei darussalam.
J Gastroenterol Hepatol. 27: 14243.Shen F Zhou H Chen G et al.An epidemiologic study on functional constipation among adult communities in Shanghai.
Zhonghua Liu Xing Bing Xue Za Zhi. 33: 296-30044.Ebling B Gulic S Jurcic D et al.Demographic, anthropometric and socioeconomic characteristics of functional constipation in Eastern Croatia.
Coll Antropol. 38: 539-54645.Prevalence of constipation among the general population: a community-based survey from India.
Gastroenterol Nurs. 37: 425-42946.Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences.
Am J Gastroenterol. 109: 876-88447.Koloski NA Jones M Young M Talley NJDifferentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
Aliment Pharmacol Ther. 41: 856-86648.Perveen I Rahman M Saha M Parvin R Chowdhury MFunctional constipation—prevalence and life style factors in a district of Bangladesh.
Mymensingh Med J. 24: 295-30449.Enck P Leinert J Smid M Köhler T Schwille-Kiuntke JFunctional constipation and constipation-predominant irritable bowel syndrome in the general population: data from the GECCO Study.
Gastroenterol Res Pract. 318601650.Schmidt FMQ De Gouveia Santos VLC De Cássia Domansky R Neves JMJConstipation: prevalence and associated factors in adults living in Londrina, Southern Brazil.
Gastroenterol Nurs. 39: 204-21151.Tamura A Tomita T Oshima T et al.Prevalence and self-recognition of chronic constipation: results of an internet survey.
J Neurogastroenterol Motil. 22: 677-68552.Long Y Huang Z Deng Y et al.Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.
Neurogastroenterol Motil. 29e1289753.Meinds RJ van Meegdenburg MM Trzpis M Broens PMAOn the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands.
Int J Colorectal Dis. 32: 475-48354.Sehonou J Sokpon C Kpossou A et al.Constipation fonctionnelle en population générale à Cotonou (Bénin): aspects cliniques et influence des facteurs nutritionnels.
PanAfrican Med J. 34: 21055.Kawamura Y Yamamoto S Funaki Y et al.Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
J Gastroenterol. 55: 27-3856.Norwood DA Dominguez LB Paredes AA et al.Prevalence and associated dietary factors of Rome IV functional gastrointestinal disorders in rural Western Honduras.
Dig Dis Sci. : 1-1057.Ohkubo H Takatsu T Yoshihara T et al.Difference in defecation desire between patients with and without chronic constipation: a large-scale internet survey.
Clin Transl Gastroenterol. 11e0023058.Werth BL Fisher MJ Williams KA Pont LGChronic constipation in the community.
J Wound, Ostomy Cont Nurs. 47: 259-26459.Physician visits in the United States for constipation: 1958 to 1986.
Dig Dis Sci. 34: 606-61160.Systematic review: the effects of fibre in the management of chronic idiopathic constipation.
Aliment Pharmacol Ther. 33: 895-90161.Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
Gut. 60: 209-21862.Luthra P Camilleri M Burr NE Quigley EMM Black CJ Ford ACEfficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
Lancet Gastroenterol Hepatol. 4: 831-84463.Oka P Parr H Barberio B Black CJ Savarino EV Ford ACGlobal prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
Lancet Gastroenterol Hepatol. 5: 908-91764.Norwood DA Dominguez L Paredes AA et al.The functional gastrointestinal disorders population-based prevalence and relationship to dietary factors in Latino populations in the resource limited setting of rural Central America.
Am J Gastroenterol. 114: S29565.Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation.
Clin Gastroenterol Hepatol. 18 (): 123866.Black CJ Burr NE Quigley EMM Moayyedi P Houghton LA Ford ACEfficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis.
Gastroenterology. 155: 1753-176367.Fukudo S Endo Y Hongo M et al.Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.
Lancet Gastroenterol Hepatol. 3: 603-61368.Nakajima A Seki M Taniguchi S et al.Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Lancet Gastroenterol Hepatol. 3: 537-54769.Ford AC Bercik P Morgan DG Bolino C Pintos-Sanchez MI Moayyedi PCharacteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
Aliment Pharmacol Ther. 39: 312-32170.Barberio B Mahadeva S Black CJ Savarino EV Ford ACSystematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria.
Aliment Pharmacol Ther. 52: 762-773
Comments (0)